Immunostherapeutics is focused on developing HLA-based biologic therapeutics for the treatment of cancer and autoimmune diseases, utilizing specific human leukocyte antigen molecules to enhance patients' immune systems, as self-described.
peer of
competitor of
Metrics
marketPRIVATE
msh_idCOM:IMMUNOSTHERAPEUTICS
localech
websitehttps://www.immunostherapeutics.com
source_refee98092f-20d5-4d37-a1a8-2d5207659289
products_or_servicesBiologic therapeutics for cancer and autoimmune disease treatment, including a pipeline of first-in-class immunotherapies.
Switzerland